Literature DB >> 20380481

Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults.

Ambrose H W Wong1, Katie Williams, Sharon Reddy, Douglas Wilson, Janet Giddy, Galit Alter, Musie Ghebremichael, Mary N Carrington, Thumbi Ndung'u, Bruce D Walker, Marcus Altfeld, William H Carr.   

Abstract

Recent studies suggest that innate immune responses by natural killer (NK) cells play a significant role in restricting human immunodeficiency virus type-1 (HIV-1) pathogenesis. Our aim was to characterize changes in NK cells associated with HIV-1 clade C disease progression. Here we used multiparametric flow cytometry (LSRII) to quantify phenotype and function of NK cells in a cross-sectional analysis of cryopreserved blood samples from a cohort of 41 chronically HIV-1-infected, treatment-naive adult South Africans. These individuals ranged in disease severity from early (CD4 count >500) to advanced HIV-1 disease (CD4 count <50). We found that the frequency of NK cells expressing KIR2DL1, an inhibitory receptor, and/or KIR2DS1, an activating receptor, tended to decrease with increasing HIV-1 viral load. We also discovered a significant increase (p < 0.05) in overall NK cell degranulation with disease progression. We found that acutely activated NK cells (CD69(pos)) were deficient in NKp46 expression ex vivo. In conclusion, we observed that with viremia and advanced HIV-1 disease, activated NK cells lack NKp46 expression, and KIR2DS1(pos) and/ or KIR2DL1(pos) NK cells are reduced in frequency. These findings suggest that modulation of receptor expression on NK cells may play a role in HIV-1 pathogenesis, and provide new insights on immunological changes in advanced HIV-1 disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380481      PMCID: PMC3111148          DOI: 10.1089/aid.2009.0176

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  38 in total

1.  Motif inference reveals optimal CTL epitopes presented by HLA class I alleles highly prevalent in southern Africa.

Authors:  Isobella Honeyborne; Almas Rathod; Rico Buchli; Dhanwanthie Ramduth; Eshia Moodley; Prinisha Rathnavalu; Senica Chetty; Cheryl Day; Christian Brander; William Hildebrand; Bruce D Walker; Photini Kiepiela; Philip J R Goulder
Journal:  J Immunol       Date:  2006-04-15       Impact factor: 5.422

2.  Recognition of peptide-MHC class I complexes by activating killer immunoglobulin-like receptors.

Authors:  C Andrew Stewart; Fanny Laugier-Anfossi; Frédéric Vély; Xavier Saulquin; Jenifer Riedmuller; Agnès Tisserant; Laurent Gauthier; François Romagné; Géraldine Ferracci; Fernando A Arosa; Alessandro Moretta; Peter D Sun; Sophie Ugolini; Eric Vivier
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

3.  CD107a as a functional marker for the identification of natural killer cell activity.

Authors:  Galit Alter; Jessica M Malenfant; Marcus Altfeld
Journal:  J Immunol Methods       Date:  2004-11       Impact factor: 2.303

4.  Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I.

Authors:  Monia Draghi; Nobuyo Yawata; Michael Gleimer; Makoto Yawata; Nicholas M Valiante; Peter Parham
Journal:  Blood       Date:  2004-11-04       Impact factor: 22.113

5.  Low perforin and elevated SHIP-1 expression is associated with functional anergy of natural killer cells in chronic HIV-1 infection.

Authors:  Galit Alter; Todd J Suscovich; Marianna Kleyman; Nickolas Teigen; Hendrik Streeck; M Tauheed Zaman; Angela Meier; Marcus Altfeld
Journal:  AIDS       Date:  2006-07-13       Impact factor: 4.177

6.  Characterization of CD56-/CD16+ natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals.

Authors:  Domenico Mavilio; Gabriella Lombardo; Janet Benjamin; Diana Kim; Dean Follman; Emanuela Marcenaro; M Angeline O'Shea; Audrey Kinter; Colin Kovacs; Alessandro Moretta; Anthony S Fauci
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-07       Impact factor: 11.205

7.  Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type.

Authors:  V Litwin; J Gumperz; P Parham; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1993-10-01       Impact factor: 14.307

8.  Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II).

Authors:  D Harrison; J H Phillips; L L Lanier
Journal:  J Immunol       Date:  1991-11-15       Impact factor: 5.422

9.  The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.

Authors:  R Biassoni; C Cantoni; M Falco; S Verdiani; C Bottino; M Vitale; R Conte; A Poggi; A Moretta; L Moretta
Journal:  J Exp Med       Date:  1996-02-01       Impact factor: 14.307

10.  Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones.

Authors:  R Biassoni; M Falco; A Cambiaggi; P Costa; S Verdiani; D Pende; R Conte; C Di Donato; P Parham; L Moretta
Journal:  J Exp Med       Date:  1995-08-01       Impact factor: 14.307

View more
  17 in total

1.  Killer-cell immunoglobulin-like receptor genotyping and HLA killer-cell immunoglobulin-like receptor-ligand identification by real-time polymerase chain reaction.

Authors:  H A Hong; A S Loubser; D de Assis Rosa; V Naranbhai; W Carr; M Paximadis; D A Lewis; C T Tiemessen; C M Gray
Journal:  Tissue Antigens       Date:  2011-09

2.  Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Authors:  Michael A Eller; Rebecca N Koehler; Gustavo H Kijak; Leigh Anne Eller; David Guwatudde; Mary A Marovich; Nelson L Michael; Mark S de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  Impact of blood processing variations on natural killer cell frequency, activation, chemokine receptor expression and function.

Authors:  Vivek Naranbhai; Pat Bartman; Dudu Ndlovu; Pamela Ramkalawon; Thumbi Ndung'u; Douglas Wilson; Marcus Altfeld; William H Carr
Journal:  J Immunol Methods       Date:  2011-01-19       Impact factor: 2.303

4.  Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.

Authors:  Caroline T Tiemessen; Maria Paximadis; Gregory Minevich; Robert Winchester; Sharon Shalekoff; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

5.  Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.

Authors:  Christina F Thobakgale; Lena Fadda; Kimberly Lane; Ildiko Toth; Florencia Pereyra; Suzane Bazner; Thumbi Ndung'u; Bruce D Walker; Eric S Rosenberg; Galit Alter; Mary Carrington; Todd M Allen; Marcus Altfeld
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

Review 6.  Immunogenetics of HIV disease.

Authors:  Maureen P Martin; Mary Carrington
Journal:  Immunol Rev       Date:  2013-07       Impact factor: 12.988

7.  Multiparametric analysis of host response to murine cytomegalovirus in MHC class I-disparate mice reveals primacy of Dk-licensed Ly49G2+ NK cells in viral control.

Authors:  Jessica Prince; Alyssa Lundgren; Michael D Stadnisky; William T Nash; Amira Beeber; Stephen D Turner; Michael G Brown
Journal:  J Immunol       Date:  2013-09-25       Impact factor: 5.422

8.  Functional advantage of educated KIR2DL1(+) natural killer cells for anti-HIV-1 antibody-dependent activation.

Authors:  S L Gooneratne; R J Center; S J Kent; M S Parsons
Journal:  Clin Exp Immunol       Date:  2016-02-04       Impact factor: 4.330

Review 9.  CD4saurus Rex &HIVelociraptor vs. development of clinically useful immunological markers: a Jurassic tale of frozen evolution.

Authors:  Andrea De Maria; Andrea Cossarizza
Journal:  J Transl Med       Date:  2011-06-16       Impact factor: 5.531

10.  KIR-HLA genotypes in HIV-infected patients lacking immunological recovery despite effective antiretroviral therapy.

Authors:  Alessandro Soria; Franca Rosa Guerini; Alessandra Bandera; Elisabetta Bolognesi; Alessia Uglietti; Caterina Fusco; Patrizia Zucchi; Renato Maserati; Giuliano Rizzardini; Mario Clerici; Andrea Gori
Journal:  PLoS One       Date:  2011-11-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.